ClinicalTrials.govpublic full text
Comparative Analysis of Cost-effectiveness Between Sulfonylureas and DPP4 Inhibitors in Combination With Metformin in Treatment of Type 2 Diabetic Patients : A Retrospective, Observational Study.
type 2 diabetes mellitus (t2dm), cost-effectiveness, sulfonylureas, dpp4 inhibitors, metformin
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 234382
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.